Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Zytoprotec Appoints Two Board Members

This article was originally published in Scrip

Executive Summary

Biotech company Zytoprotec has appointed Joerg Vienken and Norbert Riedel to its supervisory board. From 1996 to 2013, Vienken was vice president biosciences at Fresenius Medical Care and is a member of the scientific board of the Berlin-Brandenburg Center for regenerative therapies, the Institute of Biocybernetics and Biomedical Engineering of the Polish Academy of Sciences. For more than 10 years Riedel was head of research and development at Baxter and has been involved with or held positions at companies including ARIAD, Naurex (acquired by Allergan), Aptinyx, Jazz Pharmaceuticals and MediGene.






Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst